Cargando…
Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosis
BACKGROUND: Glioblastoma multiforme (GBM) is characterized by an unfavorable prognosis for patients affected. During standard-of-care chemotherapy using temozolomide (TMZ), tumors acquire resistance thereby causing tumor recurrence. Thus, deciphering essential molecular pathways causing TMZ resistan...
Autores principales: | Stillger, Maren Nicole, Chen, Chia-Yi, Lai, Zon Weng, Li, Mujia, Schäfer, Agnes, Pagenstecher, Axel, Nimsky, Christopher, Bartsch, Jörg Walter, Schilling, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022304/ https://www.ncbi.nlm.nih.gov/pubmed/36932402 http://dx.doi.org/10.1186/s12935-023-02889-8 |
Ejemplares similares
-
Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells
por: Zhao, Kai, et al.
Publicado: (2021) -
Comparative Transcriptomic Analysis of Temozolomide Resistant Primary GBM Stem-Like Cells and Recurrent GBM Identifies Up-Regulation of the Carbonic Anhydrase CA2 Gene as Resistance Factor
por: Hannen, Ricarda, et al.
Publicado: (2019) -
Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide
por: Otte, Katharina, et al.
Publicado: (2022) -
Identification of Dysregulated microRNAs in Glioblastoma Stem-like Cells
por: Evers, Lara, et al.
Publicado: (2023) -
Integrins and p53 pathways in glioblastoma resistance to temozolomide
por: Martin, Sophie, et al.
Publicado: (2012)